Skip to main content

Carly Fiorina Enters the Race

Image result for carly fiorina

If all has gone well of late, I;m on vacation as you read this. I'm posting stuff prepared well in advance, so take that into consideration if the references seem dated. 

Fiorina has run for public office exactly once. She ran for a U.S. Senate seat in 2010 and lost, to incumbent Barbara Boxer. Now she is running for the Republican nomination for President of the United States.

She is most vividly known (by the portion of the non-California public to whom she isn't just "Carly who?") as the former CEO of Hewlett-Packard, whose one signature initiative was the company's merger with Compaq.  She was fired for that, because her board thought the initiative a bungle. Yet she will argue that she was in the right, that the combined company is nowadays stronger than either or both of them would have been without her. Presumably if her campaign catches any wind under its wings at all, she'll have plenty of opportunities to make that case.

But what strikes me about Carly's career is the back-handed slap she seems to have delivered to Sarah Palin in 2008. She was an advisor to the McCain campaign herself. In that capacity, she gave a radio interview on the Palin pick on September 15th, 2008. She said then 
that Palin lacked the experience that would qualify her to run a major company like 
Hewlett-Packard. But, she added, "that's not what she's running for. Running a corporation is a 
different set of things."

[I get that from the wikipedia article under her name, I'm too lazy to do further research right now.] 
This raises a number of questions to my mind. Was she trying to help or to hurt? It sounds like 
the sort of thing she might have said had she been trying to sabotage McCain-Palin. In part it 
sounds like that because the negative gist of it was deniable. (And in the days that followed, 
she did walk it back.) Still, what is said is said. 

I'm reminded of something Ike said about Richard Nixon, when they were respectively 
President and Vice President. Asked at a news conference what Nixon had done within the 
administration, Ike said something like, "let me think about that for a week and get back to you." 
The negative sound of that, too, was deniable, but very much present, and Ike as a rule was 
only absent minded when he had present minded reasons to be.


Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.

We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…